Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,514 | 117,773 | 53,613 | 170,323 | N/A |
| Marketable Securities | 251,759 | 150,892 | 77,656 | 17,766 | N/A |
| Receivables | 57 | 309 | 662 | 955 | N/A |
| Other current assets | 1,686 | 0 | 0 | 0 | 0 |
| TOTAL | $315,077 | $272,707 | $134,913 | $189,515 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,776 | 2,600 | 2,861 | 3,888 | N/A |
| Investments And Advances | 83,030 | 50,371 | 6,115 | 0 | 0 |
| Other Non-Current Assets | 15,612 | 53 | 2,112 | 0 | 0 |
| TOTAL | $101,418 | $53,024 | $11,088 | $3,888 | $N/A |
| Total Assets | $416,495 | $325,731 | $146,001 | $193,403 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,084 | 3,232 | 4,840 | 2,823 | 0 |
| Accrued Expenses | 13,966 | 17,796 | 7,399 | 4,034 | N/A |
| Other current liabilities | N/A | N/A | 683 | 766 | N/A |
| TOTAL | $41,131 | $25,555 | $18,824 | $20,387 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,569 | 1,958 | 4,042 | 9,924 | N/A |
| Other Non-Current Liabilities | 546 | 588 | 1,466 | 2,297 | 0 |
| TOTAL | $27,562 | $3,841 | $1,466 | $61,841 | $N/A |
| Total Liabilities | $68,693 | $29,396 | $20,290 | $82,228 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,953 | 41,029 | N/A | N/A | N/A |
| Common Shares | 49 | 41 | 1 | 1 | N/A |
| Retained earnings | -422,797 | -285,672 | -202,320 | -213,686 | N/A |
| Other shareholders' equity | -239 | 55 | 317,313 | 317,279 | 0 |
| TOTAL | $347,802 | $296,335 | $125,711 | $111,175 | $N/A |
| Total Liabilities And Equity | $416,495 | $325,731 | $146,001 | $193,403 | $0 |